Basic Information
AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases, including tauopathies such as Alzheimer's disease (AD) and progressive supranuclear palsy (PSP).
AlzProtect
--
less than 15 people
January 01, 2007
contact@alzprotect.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios